Table 2.
Univariate Cox regression model results for all patients.
| Hazard ratio | Lower CL | Upper CL | Prob ChiSq | |
|---|---|---|---|---|
| ADT + docetaxel received | 4.891 | 0.803 | 29.785 | 0.0851 |
| ADT refractory, no docetaxel | 1.038 | 0.123 | 8.781 | 0.9726 |
| PSA increased | 1.85 | 0.412 | 8.305 | 0.4221 |
| Previous RT in SBRT field | 1.432 | 0.53 | 3.873 | 0.479 |
| Age <65 years | 1.764 | 0.657 | 4.738 | 0.2599 |
| CTV > 22 | 1.578 | 0.573 | 4.349 | 0.3778 |
| Gleason score > 7 | 1.197 | 0.368 | 3.898 | 0.7648 |
| ADT untreated | 2.84 | 0.498 | 16.19 | 0.24 |
| Non-lymph node site | 3.009 | 0.869 | 10.412 | 0.082 |
| Polymetastatic disease | 3.328 | 0.966 | 11.473 | 0.0568 |
| Docetaxel received | 4.162 | 1.174 | 14.751 | 0.0272 |